-
Mashup Score: 1
Patients with ER-positive, HER2-negative, ESR1-mutant advanced breast cancer experienced improvements in progression-free survival when being treated with Orserdu, study results showed.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 1
Dato-DXd (datopotamab deruxtecan) as a form of treatment compared to chemotherapy resulted in improved progression-free survival for patients with previously treated hormone receptor-positive/HER2-negative inoperable or metastatic breast cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Breast Cancer Index: Prospective Evaluation Insights from... - 1 year(s) ago
Breast Cancer Index: Prospective Evaluation Insights from Kai Treuner PhD By Kai Treuner, PhD So the breast cancer index is a test that’s been developed for the extended endocrine decision making. So in particularly women that are hormone receptor positive that usually get 5 years of endocrine therapy at the 5 year…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Breast Cancer Index: Prospective Evaluation Insights from... - 1 year(s) ago
Breast Cancer Index: Prospective Evaluation Insights from Kai Treuner PhD By Kai Treuner, PhD So the breast cancer index is a test that’s been developed for the extended endocrine decision making. So in particularly women that are hormone receptor positive that usually get 5 years of endocrine therapy at the 5 year …
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Antibody-Drug Conjugate Advancements for Breast Cancer Tr... - 1 year(s) ago
Antibody-Drug Conjugate Advancements for Breast Cancer Treatment: Updates from SABCS 2022 by Leif Ellisen MD By Leif Ellisen, MD So antibody drug conjugates, or as I’ll refer to them, ADCs are a really important new class of drugs. They’re very complicated structure in that they have three distinct components. One i…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Antibody-Drug Conjugate Advancements for Breast Cancer Tr... - 1 year(s) ago
iFrame is not supported! Antibody-Drug Conjugate Advancements for Breast Cancer Treatment: Updates from SABCS 2022 by Leif Ellisen MD By Leif Ellisen, MD So antibody drug conjugates, or as I’ll refer to them, ADCs are a really important new class of drugs. They’re very complicated structure in that they have three d…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Exciting new developments in the treatment of breast cancer have been shared by Dr. Leif Ellisen at SABCS 2022. Dr. Ellisen discussed the advancements in ADCs. @MGHMedicine #SABCS #BreastCancer #AntibodyDrugConjugates #ADCs Read and Share the Article Here: https://t.co/KQH1pbenzc https://t.co/WBqfUrGjHF
-
-
Mashup Score: 0Antibody-Drug Conjugate Advancements for Breast Cancer Tr... - 1 year(s) ago
Antibody-Drug Conjugate Advancements for Breast Cancer Treatment: Updates from SABCS 2022 by Leif Ellisen MD By Leif Ellisen, MD So antibody drug conjugates, or as I’ll refer to them, ADCs are a really important new class of drugs. They’re very complicated structure in that they have three distinct components. One i…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
For #breastcancer survivors, persistent chronic musculoskeletal pain is a common problem. New data presented at the 2022 #SABCS reported multiple types of #acupuncture help, including one that clinicians can administer without formal acupuncture training: https://t.co/yZjdKWwMR0 https://t.co/6OsGkWlQvi
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
For #breastcancer survivors, persistent chronic musculoskeletal pain is a common problem. New data presented at the 2022 #SABCS reported multiple types of #acupuncture help, including one that clinicians can administer without formal acupuncture training: https://t.co/yZjdKWwMR0 https://t.co/Zn5Zk0k1S1
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
For #breastcancer survivors, persistent chronic musculoskeletal pain is a common problem. New data presented at the 2022 #SABCS reported multiple types of #acupuncture help, including one that clinicians can administer without formal acupuncture training: https://t.co/yZjdKWwMR0 https://t.co/M95KIl0vqf
-
Promising results reveal improved progression-free survival with the use of Orserdu in patients with ER-positive, HER2-negative, ESR1-mutant advanced breast cancer. #SABCS https://t.co/LNAyETDMHe https://t.co/bho3WmIIRy